Pregnancy: During pregnancy and the lactation period the recommended daily intake of vitamin B1 is 1.2-1.4 mg. This dose may be exceeded only if the patient has a demonstrated vitamin B1 deficiency, because to date the safety of administration higher than the recommended daily dose has not been documented. There are no adequate data from the use of benfotiamine in pregnant woman. A decision on the use of Milgamma mono 150 during pregnancy in cases of severe vitamin B1 deficiency should only be taken by the attending physician after careful consideration of the risks and benefits.
Breast-feeding: Vitamin B1 passes into the human breast milk. There is insufficient information on the effect of benfotiamine in newborns/infants. Milgamma mono 150 should not be used during breast-feeding.
Sign Out